Tenders Are Invited For Medical Equipments – Virtaussytometrit

Medical Equipments – Virtaussytometrit. The Hus Group Is Requesting Offers For Two (2) Flow Cytometers To Be Purchased For The Hus Diagnostic Center Special Hematology Laboratory. The Acquisition Includes Two Devices, Their Maintenance, And Equipment -Related Accessories. In Addition, The Contracting Entity Reserves The Opportunity To Obtain One, Two Or Three Accessories By The End Of 2028. This Is An Overall Acquisition, That Is, The Purchase Is Not Divided Into Parts, As The Equipment With Maintenance And Supplies Provides A Functional Entity. Both Maintenance And Supplies Are Device -Related And It Is Not Appropriate To Divide The Purchase Into Parts. The Device Offered Must Be In Clinical Use, Ce/Ivd Approved, And At Least 12 Fluorocromies And Two Flow Cytometers, Which Simultaneously Registered With Two Light Mirror Properties, With Any Peripherals. The Products Are Described In More Detail In The Invitation To Tender And In Its Annexes. Background: The Procurement Units Laboratory Currently Has Two (2) Facscanto System And 2 Facslyric Flow Cytometers. Devices Are Purchased To Replace Facscanto System Devices. Because The Laboratory Analyzes Eg. Unique Bone Marrow And Likvor Samples, The Laboratory Must Take Into Account When Purchasing Reliability, For Example. In Such A Way That All Antibody Combinations In Use Can Be Driven By All Flow Cytometers In The Laboratory, And In The Event Of Any Failure Of The Equipment, Samples Are Not Analyzed. The Laboratory Also Has A Limited Amount Of Space Available For Equipment Placement. The Laboratory Performs About 8,000 Flow Cytometric Studies Each Year, Including Diagnostic And Distribution Of Hemato-Lymphitic Malignitions, The Treatment Monitoring/Residual Disease Of The Aforementioned Disease, Immunological Examinations, Cd34-Positive Stem Cells. The Laboratory Serves Eg. Hus Cancer Center And Children And Adolescent Diseases, Which Participate In Nordic And International Patient Care Programs. Flow Cytometric Residual Disorder Analytics Is Part Of Childrens Acute Leukemio And Myeloma Treatment Programs And Has Been Instructed In A Uniform Way In All Laboratories In Patient Care Programs. The Guidelines Include: Adjusting The Devices To The Agreed Level, The Use Of Certain Antibody Panels And The Driving Of At Least 5 Million Leukococy Events Into A Single File, With A Total Number Of Events That Are Driven To The File. It Must Be Possible For The Device To Be Purchased To Conduct Residual Disease Examinations As Required By The Treatment Programs And Its Files Must Be Analyzed By The Laboratory Analysis Programs Used In The Laboratory. The File Analysis Is Used For Becton Dickinsons Facsdiva ™ And Cytognosin Infinicyt ™ Software. The Goal Is To Use Tendering To Get The Selections Safe And In Use In The Systems Summary

Refer document

FileName	File Description
Global Tender Document	Tender Notice